Interleukin Genetics' Q1 Fall 30 Percent | GenomeWeb

NEW YORK (GenomeWeb News) – Interleukin Genetics reported yesterday that its first-quarter revenues declined 30 percent and its net loss rose 32 percent, as its consumer product sales and contract research revenue fell.

The Waltham, Mass.-based genetic test maker brought in total revenues of $1.9 million, down from $2.7 million. Its consumer products sales fell to $1.5 million from $2 million year over year, while its contract research revenues were $203,687 versus $537,013 the year before. The firm's genetic testing service revenue increased to $137,511 from $101,752.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: intellectual property landscape of CRISPR genome editing, and more.

A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.

Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.

Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.